This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Richter Gedeon Nyrt.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Willie Roger Earley: Innovator in Autism Treatment
Introduction
Willie Roger Earley is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autism spectrum disorder. His innovative work has the potential to impact many lives.
Latest Patents
Earley holds a patent for "Carbamoyl cyclohexane derivatives for treating autism spectrum disorder." This invention relates to trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea (cariprazine), its salts, close analogs, derivatives, pharmaceutical compositions, metabolites, and combinations. The primary objective of this invention is to treat one or more symptoms of autism. Additionally, cariprazine and its derivatives are suitable for treating conditions such as Asperger's syndrome, atypical autism, Rett syndrome, childhood disintegrative disorder, attention deficit hyperactivity disorder (ADHD), and sensory integration dysfunction. Earley has 1 patent to his name.
Career Highlights
Willie Roger Earley is associated with Richter Gedeon Nyrt., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the field.
Collaborations
Earley has collaborated with notable colleagues, including Viktor Román and Nika Adham-Parangi. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Willie Roger Earley's contributions to the treatment of autism spectrum disorder through his patented invention highlight his commitment to improving lives through innovation. His work exemplifies the impact that dedicated inventors can have in the medical field.